Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker
03/27/2019
Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker
Topics: deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer, lynphoma, CTC cluster, melanoma
03/12/2019
Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression
Topics: FFPE, deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, Multiple myeloma, CMMCs
Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients
Topics: CTCs, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer
Copy Number Alteration Profiling of Single Circulating Tumor Cells which May Be used to Predict Response to Therapy
Topics: CTCs, DEPArray NxT, NGS, CELLSEARCH, Liquid biopsy, Precision Medicine, low-pass, copy number alteration
Liquid Biopsy Test for Circulating Tumor Cells Marks Its First Entry into U.S. Diagnostics Market
Topics: CTCs, deparray, CELLSEARCH, acquisition, CTC test, Liquid biopsy
Only FDA-Cleared CTC test to join Company’s Portfolio of Diagnostics
Topics: CTCs, single-cell isolation, deparray, CELLSEARCH
